U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07428889) titled 'Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement' on Feb. 02.
Brief Summary: The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Adult
Intervention:
DIETARY_SUPPLEMENT: Proprietary Nutritional Supplement
1000 mg nicotinamide metabolites and plant extracts, taken orally, daily for 60 days
DIETARY_SUPPLEMENT: Placebo Supplement
1000 mg maltodextrin, taken orally, daily for 60 days
Recruitment Stat...